Allurion Technologies Inc. (ALUR)
Market Cap | 60.44M |
Revenue (ttm) | 48.78M |
Net Income (ttm) | -58.20M |
Shares Out | 47.97M |
EPS (ttm) | -3.70 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 936,324 |
Open | 1.100 |
Previous Close | 1.120 |
Day's Range | 1.050 - 1.290 |
52-Week Range | 0.830 - 10.940 |
Beta | -0.26 |
Analysts | Strong Buy |
Price Target | 5.00 (+296.83%) |
Earnings Date | Aug 13, 2024 |
About ALUR
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts. [Read more]
Financial Performance
In 2023, ALUR's revenue was $53.47 million, a decrease of -16.73% compared to the previous year's $64.21 million. Losses were -$82.30 million, 102.5% more than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ALUR stock is "Strong Buy." The 12-month stock price forecast is $5.0, which is an increase of 296.83% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/8/5/press9-2502277.jpg)
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced the pricing of an underwritten public off...
![](https://cdn.snapi.dev/images/v1/h/j/press7-2497282.jpg)
Allurion Announces Launch of Offering of Common Stock and Warrants
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it has launched an underwritten publ...
![](https://cdn.snapi.dev/images/v1/k/m/press16-2487811.jpg)
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a study demonstrating an average...
![](https://cdn.snapi.dev/images/v1/j/j/press14-2473125.jpg)
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the American Soci...
![](https://cdn.snapi.dev/images/v1/w/h/press17-2463444.jpg)
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Ojas A. Buch as its new Chief Ope...
![](https://cdn.snapi.dev/images/v1/4/q/press6-2453512.jpg)
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the expansion of its Artificial Intelligence (AI)-p...
![](https://cdn.snapi.dev/images/v1/h/c/conf4-2452536.jpg)
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
NATICK, Mass.--(BUSINESS WIRE)--Allurion to Participate in Two Upcoming Investor Conferences in June 2024.
![](https://cdn.snapi.dev/images/v1/a/j/press16-2431909.jpg)
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three scientific presentations at the 31st European...
![](https://cdn.snapi.dev/images/v1/b/q/press9-2429233.jpg)
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports First Quarter 2024 Financial Results and Provides Business Update.
![](https://cdn.snapi.dev/images/v1/q/p/press20-2405896.jpg)
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three oral scientific presentations at the 12th Con...
![](https://cdn.snapi.dev/images/v1/z/9/press20-2399702.jpg)
Allurion Announces Preliminary First Quarter 2024 Results
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary, unaudited results for the fi...
![](https://cdn.snapi.dev/images/v1/a/z/press2-2375775.jpg)
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
NATICK, Mass.--(BUSINESS WIRE)--Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments.
![](https://cdn.snapi.dev/images/v1/v/k/press2-2356257.jpg)
Allurion Expands Virtual Care Suite to the United States
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the commercial availability of its comprehensive Vi...
![](https://cdn.snapi.dev/images/v1/p/r/press7-2335055.jpg)
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance.
![](https://cdn.snapi.dev/images/v1/f/3/press6-2319827.jpg)
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of its newest board member and Audi...
![](https://cdn.snapi.dev/images/v1/c/o/conf14-2306342.jpg)
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
NATICK, Mass.--(BUSINESS WIRE)--Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024.
![](https://cdn.snapi.dev/images/v1/e/s/press20-2248605.jpg)
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Brendan Gibbons as its new Chief ...
![](https://cdn.snapi.dev/images/v1/0/x/press14-2240415.jpg)
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that the Somerset NHS Foundation Trust (FT) is the ...
![](https://cdn.snapi.dev/images/v1/i/i/press9-2240218.jpg)
World first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that the Somerset NHS Foundation Trust (FT) is the ...
![](https://cdn.snapi.dev/images/v1/v/r/press7-2232363.jpg)
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced further expansion of its Virtual Care Suite (VCS) di...
![](https://cdn.snapi.dev/images/v1/t/v/press9-2225550.jpg)
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a randomized, double-blind study...
![](https://cdn.snapi.dev/images/v1/p/r/press12-2220233.jpg)
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
NATICK, Mass.--(BUSINESS WIRE)--Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook.
![](https://cdn.snapi.dev/images/v1/i/h/press17-2217987.jpg)
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced results of research that highlighted the positive i...
![](https://cdn.snapi.dev/images/v1/h/d/press1-2213095.jpg)
Allurion's Digital Platform Gains Traction with Expanded Strategic Partnership
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced an expanded commercial agreement with Weight Doctors...
![](https://cdn.snapi.dev/images/v1/p/r/press13-2154475.jpg)
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update.